Biogen Inc (NASDAQ:BIIB)
| 285.50 Delayed Data As of Jan 17 |  -0.64 / -0.22%Today’s Change | 215.78 Today|||52-Week Range 344.00 | -3.78% Year-to-Date |
Latest BIIB News | Press Releases
| Why Biogen Stock Slumped Last Year Jan 16 / MotleyFool.com - Paid Partner Content | Better Buy: Biogen vs. Gilead Sciences Jan 11 / MotleyFool.com - Paid Partner Content |
| 5 Reasons 2020 Will Be a Big Year for Ionis Pharmaceuticals Jan 16 / MotleyFool.com - Paid Partner Content | Better Buy: AbbVie vs. Biogen Jan 08 / MotleyFool.com - Paid Partner Content |
| New Research Shows Probiotics Can Help Prevent Parkinson's Jan 14 / MotleyFool.com - Paid Partner Content | Better Buy: Gilead Sciences vs. Biogen Jan 05 / MotleyFool.com - Paid Partner Content |
| Biogen Buys Azheimer's and Parkinson's Drug From Pfizer Jan 13 / MotleyFool.com - Paid Partner Content |
Today’s Trading
| Previous close | 286.14 |
| Today’s open | 287.32 |
| Day’s range | 284.90 - 288.00 |
| Volume | 1,765,147 |
| Average volume (3 months) | 2,034,657 |
| Market cap | $53.5B |
Data as of 4:00pm ET, 01/17/2020
Growth & Valuation
| Earnings growth (last year) | +81.10% |
| Earnings growth (this year) | +26.34% |
| Earnings growth (next 5 years) | +5.99% |
| Revenue growth (last year) | +9.67% |
| P/E ratio | 10.2 |
| Price/Sales | 5.13 |
| Price/Book | 4.34 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| ILMNIllumina Inc | -1.24 | -0.38% |
| GILDGilead Sciences | -0.22 | -0.35% |
| BMRNBiomarin Pharmaceuti... | -0.86 | -0.96% |
| EXASExact Sciences Corp | -1.72 | -1.92% |
Data as of 4:00pm ET, 01/17/2020
Financials
| Next reporting date | January 29, 2020 |
| EPS forecast (this quarter) | $7.92 |
| Annual revenue (last year) | $12.1B |
| Annual profit (last year) | $4.4B |
| Net profit margin | 36.76% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Cambridge, Massachusetts |
Forecasts
